Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN
Status:
Active, not recruiting
Trial end date:
2025-12-25
Target enrollment:
Participant gender:
Summary
This trial is a multicenter, prospective, single-arm exploratory clinical study to evaluate
the efficacy and safety of Penpulimab injection combined with cetuximab in the first-line
treatment of recurrent/metastatic squamous cell carcinoma of the head and neck